Quantbot Technologies LP Invests $2.40 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Quantbot Technologies LP acquired a new stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 103,621 shares of the company's stock, valued at approximately $2,404,000. Quantbot Technologies LP owned about 0.06% of Option Care Health as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Quarry LP raised its holdings in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after buying an additional 2,628 shares during the last quarter. Blue Trust Inc. boosted its position in shares of Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after buying an additional 681 shares during the period. Finally, Venturi Wealth Management LLC boosted its position in shares of Option Care Health by 2,621.3% during the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after buying an additional 4,561 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Remove Ads

Option Care Health Trading Up 0.5 %

Shares of NASDAQ OPCH traded up $0.17 during mid-day trading on Thursday, hitting $35.20. 1,224,299 shares of the company traded hands, compared to its average volume of 1,643,535. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock has a market capitalization of $5.78 billion, a price-to-earnings ratio of 29.58, a PEG ratio of 2.30 and a beta of 1.33. The business has a 50 day moving average of $32.24 and a two-hundred day moving average of $28.37.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 0.64% of the stock is owned by insiders.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research analyst reports. Barrington Research raised their price target on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Finally, UBS Group assumed coverage on Option Care Health in a research note on Thursday, December 5th. They set a "neutral" rating and a $26.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.